BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meng QB, Yu JC, Kang WM, Ma ZQ, Zhou WX, Li J, Zhou L, Cao ZJ, Tian SB. [Expression of doublecortin-like kinase 1 in human gastric cancer and its correlation with prognosis]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013;35:639-644. [PMID: 24382242 DOI: 10.3881/j.issn.1000-503x.2013.06.010] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
Number Citing Articles
1 Shi W, Li F, Li S, Wang J, Wang Q, Yan X, Zhang Q, Chai L, Li M. Increased DCLK1 correlates with the malignant status and poor outcome in malignant tumors: a meta-analysis. Oncotarget 2017;8:100545-57. [PMID: 29246000 DOI: 10.18632/oncotarget.20129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Fan M, Qian N, Dai G. Expression and prognostic significance of doublecortin-like kinase 1 in patients with hepatocellular carcinoma. Oncol Lett 2017;14:7529-37. [PMID: 29344199 DOI: 10.3892/ol.2017.7082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
3 Kang XL, He LR, Chen YL, Wang SB. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis. World J Gastroenterol 2020; 26(43): 6853-6866 [PMID: 33268966 DOI: 10.3748/wjg.v26.i43.6853] [Reference Citation Analysis]
4 Agulto RL, Rogers MM, Tan TC, Ramkumar A, Downing AM, Bodin H, Castro J, Nowakowski DW, Ori-McKenney KM. Autoregulatory control of microtubule binding in doublecortin-like kinase 1. Elife 2021;10:e60126. [PMID: 34310279 DOI: 10.7554/eLife.60126] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mirzaei A, Tavoosidana G, Rad AA, Rezaei F, Tavakoli-Yaraki M, Kadijani AA, Khalili E, Madjd Z. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer? Tumour Biol 2016;37:2405-14. [PMID: 26383518 DOI: 10.1007/s13277-015-3989-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
6 Wu X, Qu D, Weygant N, Peng J, Houchen CW. Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments. Cancers (Basel) 2020;12:E274. [PMID: 31979136 DOI: 10.3390/cancers12020274] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
7 Vijai M, Baba M, Ramalingam S, Thiyagaraj A. DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer. Oncol Lett 2021;22:850. [PMID: 34733368 DOI: 10.3892/ol.2021.13111] [Reference Citation Analysis]
8 Dai J, Li ZX, Zhang Y, Ma JL, Zhou T, You WC, Li WQ, Pan KF. Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival. Clin Transl Gastroenterol 2019;10:e00004. [PMID: 30702489 DOI: 10.14309/ctg.0000000000000004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]